Advik Laboratories share news, announcements and annual reports
BSE: 531686Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 26 Oct 2026. Previous close ₹2.08.
26 Oct: open ₹2.08, high ₹2.08, low ₹2.08
- Under BSE's graded surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3.98 Cr5,167th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 58.03
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −180.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 109.84
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,364
Advik Laboratories share news and announcements
601 announcements, routine notices left out, newest first. Page 8 of 13.
Apr 2020
21 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 010 Apr · Confirmation On Non Applicability Of The Criteria Specified Under SEBI Circular No. SEBI/HO/DDHS CIR/P/2018/144 Dated 26Th November, 2018 Read With Circular No. LIST/COMP/05/2019-20 Dated April 11, 2019
7 Apr · Legal
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities
Feb 2020
Jan 2020
30 Jan · Board meeting
Meeting on 13 Feb 2020: quarterly results16 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....13 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2019
Nov 2019
4 Nov · Board meeting
Meeting on 13 Nov 2019: quarterly results
Oct 2019
16 Oct · CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS REGULATIONS), 2015
15 Oct · Compliance Certificate For The Period Ended 30.09.2019
11 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2019
28 Sep · Reg. 34 (1) Annual Report
26 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....2 Sep · Reg. 34 (1) Annual Report
Aug 2019
16 Aug · Board meeting
Meeting on 23 Aug 201916 Aug · Notice Of Board Meeting To Consider The Sale Of Manufacturing Unit Of The Company
1 Aug · Board meeting
Meeting on 12 Aug 2019: quarterly results
Jul 2019
19 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....12 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2019